Siloam Hospitals Enhances AI Integration Through New Partnerships
Siloam Hospitals partners with Philips to enhance AI in healthcare. 🤖📈 Focus areas include radiology, telemedicine, and training.
October 14, 2024
Follow us
latest articles
Discover the newest research about AI innovations in 🧬 Genetics.
Smart variant filtering – A blueprint solution for massively parallel sequencing-based variant analysis.
Massively parallel sequencing enhances genomic insights but complicates clinical decisions. 🤖 A new AI-based solution aims to streamline variant analysis. 🧬
October 13, 2024
Machine learning-based discovery of UPP1 as a key oncogene in tumorigenesis and immune escape in gliomas.
Recent research highlights UPP1’s role in glioma progression and immune evasion. Promising target for future therapies. 🧠🔬
October 9, 2024
Revolutionizing Cancer Treatment with AI-Driven Protein Analysis
AI-driven protein analysis transforms cancer treatment, enhancing diagnosis and drug design. Promising advancements in personalized healthcare. 🧬💡
October 6, 2024
Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases.
Innovative technologies are vital for diagnosing rare diseases. 🧬 Our review highlights expert recommendations for improved patient outcomes. 🌍
September 30, 2024
Decoding Missense Variants by Incorporating Phase Separation via Machine Learning.
Recent research highlights a machine learning model, PSMutPred, predicting missense variant impacts on phase separation. 🧬🔍
September 30, 2024
Precision molecular insights for prostate cancer prognosis: tumor immune microenvironment and cell death analysis of senescence-related genes by machine learning and single-cell analysis.
New research highlights aging genes’ role in prostate cancer prognosis. A predictive model shows promise for improved outcomes. 📊🔬
September 28, 2024
Comprehensive characterization of long QT syndrome-associated genes in cancer and development of a robust prognosis model.
Long QT syndrome (LQTS) impacts cancer treatment. 🩺 A new prognostic model may enhance patient outcomes. 📊
September 25, 2024
A microRNA diagnostic biomarker for amyotrophic lateral sclerosis.
A recent PubMed article highlights an eight-microRNA diagnostic signature for amyotrophic lateral sclerosis. 🧬🔬 Promising for patient outcomes!
September 17, 2024
Radiomics and quantitative multi-parametric MRI for predicting uterine fibroid growth.
New research highlights a predictive model using MRI to assess uterine fibroid growth rates. 📈🩻 Promising clinical implications ahead.
September 16, 2024